Atazanavir–bilirubin interaction: a pharmacokinetic–pharmacodynamic model [Corrigendum]
Lozano R, Domeque N, Apesteguia AF. Clinical Pharmacology: Advances and Applications. 2013;5(1):153–159. On page 155, "Deriving Michaelis–Menten’s equation,26 View original paper by Lozano R, Domeque N, Apesteguia AF
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Published: |
Dove Medical Press,
2013-11-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_5b06dddba05b4e019fa00366bcc1ae84 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Lozano R |e author |
| 700 | 1 | 0 | |a Domeque N |e author |
| 700 | 1 | 0 | |a Apesteguia AF |e author |
| 245 | 0 | 0 | |a Atazanavir–bilirubin interaction: a pharmacokinetic–pharmacodynamic model [Corrigendum] |
| 260 | |b Dove Medical Press, |c 2013-11-01T00:00:00Z. | ||
| 500 | |a 1179-1438 | ||
| 520 | |a Lozano R, Domeque N, Apesteguia AF. Clinical Pharmacology: Advances and Applications. 2013;5(1):153–159. On page 155, "Deriving Michaelis–Menten’s equation,26 View original paper by Lozano R, Domeque N, Apesteguia AF | ||
| 546 | |a EN | ||
| 690 | |a Therapeutics. Pharmacology | ||
| 690 | |a RM1-950 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Clinical Pharmacology: Advances and Applications, Vol 2013, Iss Issue 1, Pp 175-176 (2013) | |
| 787 | 0 | |n http://www.dovepress.com/corrigendumatazanavirndashbilirubin-interaction-a-pharmacokinetic-a15066 | |
| 787 | 0 | |n https://doaj.org/toc/1179-1438 | |
| 856 | 4 | 1 | |u https://doaj.org/article/5b06dddba05b4e019fa00366bcc1ae84 |z Connect to this object online. |